In-situ formation of liposome of rifampicin: Better availability for better treatment

Current Drug Delivery

Volumn 6, Issue 5, 2009, Pages 461-468

  Gaur, Praveen Kumar ^a   Mishra, Shikha ^a   Gupta, V B ^b   Rathod, M S ^b   Purohit, Suresh ^c   Savla, Bhavin A ^d  

^a ITS Paramedical College (Pharmacy)   (India)

^b B R NAHATA COLLEGE OF PHARMACY   (India)

^c Marwar Pharmacy College   (India)

^d R and D Section   (India)

Author keywords

Aerosol; Alveoli; In situ; Krebs Henseleit solution; Liposome; Rifampicin; Tuberculosis

Indexed keywords

LIPOSOME; RIFAMPICIN;

AEROSOL; ARTICLE; CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG STABILITY; DRUG SYNTHESIS; DRUG TARGETING; LUNG ALVEOLUS MACROPHAGE; PRIORITY JOURNAL; TUBERCULOSIS;

ADMINISTRATION, INHALATION; AEROSOLS; ANIMALS; ANTIBIOTICS, ANTITUBERCULAR; DRUG CARRIERS; DRUG STABILITY; LIPOSOMES; LUNG; PHARMACEUTIC AIDS; RATS; RIFAMPIN;

EID: 72149134195     PISSN: 15672018     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720109789941623     Document Type: Article

References (39)

1. Mandell, G.L.; Sande, H. A. In Antimicrobial agents; The Pharmacological Basis of Therapeutics; Gilman, G.A.; Goodman, A.; Eds.; 7th ed., Macmillan, New York, 1985; pp. 1202-1205.
2. Shek, P.N.; Suntres, Z.E.; Brooks, J.I. Liposomes in pulmonary applications: physicochemical considerations, pulmonary distribution and antioxidant delivery. J. Drug Target., 1994, 2, 431-442.
3. 99m-Technetium as a marker of liposome disposition and clearance in the human lung. Int. J. Pharm., 1985, 26, 303.
4. Farr, S.J.; Kellaway, I.W.; Carman-Meaking, B. Assessing the potential of aerosol generated liposomes from pressurized pack formulations. Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages. J. Control. Release, 1987, 5, 119.
5. Vyas, S.P.; Khanna, M.E.; Jain, Sanyog; Mishra V.; Singh, Paramjit. Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages. Int. J. Pharm., 2004, V-269, 37.
6. Vyas, S.P.; Quraishi, Shama; Gupta, Swati. Aerosolized liposome-based delivery of amphotericin B to alveolar macrophages. Int. J. Pharm., 2005, 296, 12.
7. Purohit, S. D.; Gupta, M. L.; Meena, R. C.; Jatn, D. K.; Sarkar, S. K.; Gupta. P. R. Rifampicin Aerosol Administration in Guinea-Pigs (An Experimental Study). Indian J. Pharm., 1989, 21, 100-103.
8. Saito, H.; Tomioka, H. Therapeutic Efficacy of Liposome-Entrapped Rifampin against Mycobacterium avium Complex Infection Induced in Mice. Antimicrob. Agents Ch., 1989, 33(4), 429-433. (Pubitemid 19094267)
9. Deol, P.; Khuller, G.K.; Joshi, K. Therapeutic Efficacies of Isoniazid and Rifampin Encapsulated in Lung-Specific Stealth Liposomes against Mycobacterium tuberculosis Infection Induced in Mice. Antimicrob. Agents Ch., 1997, 41(6), 1211-1214. (Pubitemid 27231415)
10. Deol, Parampal; Khuller, G.K. Lung specific stealth liposomes: stability, biodistribution and toxicity of liposomal antitubercular drugs in mice. Biochim. Biophys. Acta, 1997, 1334, 161-172.
11. Bermúdez, M.; Martinez, E.; Mora, M.; Sagristá, M.L.; de Madariaga, M.A. Molecular and physicochemical aspects of the interactions of the tuberculostatics ofloxacin and rifampicin with liposomal bilayers: a 31P-NMR and DSC study. Colloids Surfaces A, 1999, 158, 59-66. (Pubitemid 29509879)
12. Labana, S.; Pandey, R.; Sharma, S.; Khuller, G.K. Chemotherapeutic activity against murine tuberculosis of once weekly administered drugs (isoniazid and rifampicin) encapsulated in liposomes. Int. J. Antimicrob. Agents, 2002, 20, 301-304.
13. Rodrigues, C.; Gameiro, P.; Prieto, M.; De Castro, Baltazar. Interaction of rifampicin and isoniazid with large unilamellar liposomes: spectroscopic location studies. Biochim. Biophys. Acta, 2003, 1620, 151-159.
14. Gürsoy, A.; Kut, E.; Özkirimli; Su. Co-encapsulation of isoniazid and rifampicin in liposomes and characterization of liposomes by derivative spectroscopy. Int. J. Pharm. 2004, 271, 115-123.
15. Zaru, M.; Mourtas, S.; Klepetsanis, P.; Fadda, A.M.; Antimisiaris, S.G. Liposomes for drug delivery to the lungs by nebulization. Eur. J. Pharm. Biopharm., 2007, 67, 655-666. (Pubitemid 47576612)
16. Sorokoumova, G. M.; Vostrikov, V. V.; Selishcheva, A. A.; Rogozhkina, E. A.; Kalashnikova, T. Yu.; Shvets, V. I.; Golyshevskaya, V. I.; Martynova, L. P. ; Erokhin. V. V. Bacteriostatic Activity and Decomposition Products of Rifampicin in Aqueous Solution and Liposomal Composition. Pharm. Chem. J., 2008, 42 (8), 475-478.
17. Takenaga, M.; Ohta, Y.; Tokura, Y. ; Hamaguchi, A. ; Igarashi, R.; Disratthakit, A.; Doi. N. 2008. Lipid Microsphere Formulation Containing Rifampicin Targets Alveolar Macrophages. Drug Deliv., 2008, 15, 169-175.
18. Changsan, N.; Chan, H.-K.; Separovic, F.; Srichana, T. Physicochemical Characterization and Stability of Rifampicin Liposome Dry Powder Formulations for Inhalation. J. Pharm. Sci., 2009, 98(2), 628-639.
19. Dhand, R. Special problems in aerosol delivery: artificial airways. Respire. Care., 2000, 45, 636.
20. Bhavane, R.; Karathanasis, E.; Annapragada, A.V. Agglomerated vesicle technology: a new class of particles for controlled and modulated pulmonary drug delivery. J. Control. Release, 2003, 93, 15.
21. Niven, R.W.; Carvajal, T.M.; Schreir, H. Nebulization of liposome III.The effect of operating conditions and local environment, Pharm. Res., 1992, 9(4). 515-520.
22. Mcgrath, J.J. Cryomicroscopy of liposome system as simple models to study cellular freezing response. Cryobiology, 1984, 21, 81.
23. Burkhard, W.V.; Ricardo, B. M. W.; Schreier, H. Amikacin liposomes characterization, aerosolization, and in vitro activity against Mycobacterium avium- intracellular in alveolar macrophages. Int. J. Pharm., 1992, 78, 227.
24. Tabake, A.; Hoffer, E.; Taitelman, U. Evaluation of a liposome system for the delivery of desferrioxamine to lungs in rats. J. Pharm. Pharmacol., 1994, 46, 786.
25. Fraser D.S.; Yong, P. M.; Price, R.; Edge, T.S.; Lewis, D. The potential use of Raman mapping to investigate in vitro deposition of combination pressurized metered dose inhalers. AAPS J., 2004, 6, 1.
26. Vyas, S.P.; Sakthivel, T. Pressurized pack-based liposomes for pulmonary targeting of isosprenaline - development and characterization. J. Microencapsul., 1994, 11, 373-380. (Pubitemid 24209452)
27. Farr, S.J.; Kellaway, I.W.; Carman-Meakin, B. Comparison of solute partitioning and efflux in liposomes formed by a conventional and an aerosolized method. Inter. J. Pharmaceut., 1989, 51, 39-46. (Pubitemid 19087830)
28. Hallworth, G.W.; Westmoreland, D.G. The Twin impinger: a simple device for assessing the delivery of drugs from metered dose pressurized aerosol inhalers. J. Pharm. Pharmacol., 1987, 39, 966.
29. Kirk, W. F. In Vitro method of comparing clouds produced from inhalation aerosols for efficiency in penetration of airways. J. Pharm. Sci., 1972, 61, 262.
30. Vipin, B.G.; M. Pharma Thesis, Lung targeting of cromolyn sodium using aerosolized liposome. Dr.H.S.G.V, Sagar, M.P, 1991.
31. Sciarra, J.J.; Cutie, A.J. In The Theory & Practice of Industrial Pharmacy; Lachman, L; Liberman, A; Kanig, J.L, Eds.; 3 ed., Lea & Febiger: Philadelphia, 1987, pp. 589-618.
32. Byron, P.R.; Roberts, N. A novel dosing method for drug administration to the airways of the isolated perfused rat lung. J. Pharm. Sci., 1988, 77, 693.
33. Feddah, M.R.; Brown, K.F.; Gipps, E.M. In-vitro Characterization of metered dose inhaler versus dry powder inhaler glucocorticoid products: Influencing of inspiration flow rates. J. Pharm. Sci., 2000, 3, 317.
34. Yammada, K.; Kamada, N.; Odomi, M. Yamamoto, A. Carrageenans can regulate the pulmonary absorption of anti-asthmatic drugs and their retention in the rat lung tissues with out any membrane damage. Int. J. Pharm., 2005, 293, 63.
35. Vyas, S.P.; Khar, R. K. Targeted and controlled drug delivery: novel carrier systems, CBS publishers: New Delhi, 2002, pp.- 219-243.
36. Kanaoka, E.; Hirano, K. Stabilization of aerosolized inf-γ by liposomes. Int. J. Pharm., 1999, 188, 165.
37. Kammy, K. M.; Bridges, P.A.; Taylor, M.G. The stability of liposome to ultrasonic nebulization. Int. J. Pharm., 1996, 145, 96.
38. Taylor, K.M.G.; Taylor, G.; Kellaway, I.W.; Stevens, J. The stability of liposomes on nebulization. Int. J. Pharm., 1990, 58, 57-61.
39. Edwards, David A.; Schneck, Ingrid Zhang, Faith.; Davis, Anthony M. J.; Chen, Hongming Langer, Robert. Spontaneous Vesicle Formation at Lipid Bilayer Membranes. Biophys. J., 1996, 71, 1208-1214.